retatrutide obesity triple hormone receptor agonist mechanism trial clinical Retatrutide Clinical Trial – My Endo Consult retatrutide – retatrutide triple hormone receptor agonist

Lipolysis does not only burn fat

There is no universal 'morning or night' rule that applies to all GLP-1 medications

Watanabe, J

BCBSTX is hosting multiple in-person and virtual opportunities in the Houston and Dallas regions with enrollment specialists available in English and Spanish to answer questions and simplify the enrollment process

| Side effects compared | How to choose between them | If youre already on Mounjaro or Wegovy injections | Maintaining muscle mass | Frequently asked questions | Take home message The Wegovy pill (oral semaglutide 25 mg) is the first oral GLP-1 medication licensed for weight loss in the UK, available privately on prescription after the MHRA approved it on 11 June 2026